Glucodip-M XR 50 mg+1000 mg (Tablet (Extended Release))
Unit Price: ৳ 22.00 (3 x 10: ৳ 660.00)
Strip Price: ৳ 220.00
Medicine Details
Category | Details |
---|---|
Generic | Sitagliptin metformin hydrochloride |
Company | Sun pharmaceutical bangladesh ltd |
Also available as |
Indications
- Adjunct to diet and exercise for type 2 diabetes mellitus
- Improves glycemic control
Pharmacology
- Combines sitagliptin and metformin
- Dipeptidyl peptidase-4 (DPP-4) inhibitor
- Biguanide class of drugs
- Slows inactivation of incretin hormones
- Regulates glucose homeostasis
- Increases insulin release and decreases glucagon levels
Dosage & Administration
- Individualized dosage based on patient's current regimen
- Maximum recommended daily dose of 100mg sitagliptin and 2000mg metformin
- Twice daily with meals
- Gradual dose escalation to reduce gastrointestinal side effects
- Adjust dosing based on effectiveness and tolerability
- Administer extended-release tablet once daily with a meal
- Consideration for co-administration with insulin secretagogue or insulin
Interaction
- Use with caution with cationic drugs eliminated by renal tubular secretion
- Metformin may decrease the anticoagulant effect of phenprocoumon
- Levothyroxine can reduce the hypoglycemic effect of metformin
Contraindications
- Renal disease or renal dysfunction
- Acute or chronic metabolic acidosis
- History of serious hypersensitivity reaction
- Use temporarily discontinued for patients undergoing radiologic studies with iodinated contrast materials
Side Effects
- Common adverse reactions include diarrhea, upper respiratory tract infection, and headache
- Hypoglycemia potential with combination therapy
- Nasopharyngitis reported with sitagliptin monotherapy
- Common adverse reactions due to initiation of metformin therapy include diarrhea, nausea/vomiting, flatulence, and headache
Pregnancy & Lactation
- Pregnancy Category B
- Caution recommended during lactation due to unknown excretion of sitagliptin in human milk
Precautions & Warnings
- Lactic acidosis risk with metformin accumulation
- Monitoring of thyroid-stimulating hormone (TSH) levels recommended in patients with hypothyroidism
- Long-term treatment associated with decrease in vitamin B12 serum levels
- Postmarketing reports of acute renal failure, pancreatitis, and allergic reactions
Overdose Effects
- Usual supportive measures for sitagliptin overdose
- Metformin is dialyzable with potential for hemodialysis in overdosage
Therapeutic Class
- Combination Oral hypoglycemic preparations
Storage Conditions
- Store below 25°C in a dry place away from light
- Keep out of reach of children
- Use only on prescription of a registered physician
Related Brands
- SB-Metsita 50 mg+1000 mg (Tablet) - sunman-birdem-pharma-ltd
- SB-Metsita 50 mg+500 mg (Tablet) - sunman-birdem-pharma-ltd
- Sitagil M 100 mg+1000 mg (Tablet (Extended Release)) - incepta-pharmaceuticals-ltd
- Sitaglap M 50 mg+500 mg (Tablet) - euro-pharma-ltd
- Sitaglap M 50 mg+1000 mg (Tablet) - euro-pharma-ltd